Tumour Board & Precision Medicines
- TUMOUR BOARD · PRECISION MEDICINE
Where Every Case Gets Multiple Expert Eyes
Every cancer diagnosis is unique, and no single treatment approach is suitable for every patient. At Apulki Medical Centre, the Tumour Board & Precision Medicines programme brings together the expertise of multiple specialists to develop personalised treatment plans based on the patient’s diagnosis, clinical condition, molecular profile, and overall treatment goals. This collaborative approach ensures that every treatment decision is carefully evaluated from multiple clinical perspectives, enabling patients to receive comprehensive, evidence-based cancer care.
- Why It Matters
Many Specialists, One Unified Treatment Plan
- A Tumour Board is a multidisciplinary panel of experts that reviews complex cancer cases before treatment begins or when changes in the treatment strategy are required.
- At Apulki Medical Centre, these discussions involve medical oncologists, radiation oncologists, surgical oncologists, pathologists, radiologists, molecular diagnosticians, and other specialists who work together to evaluate every aspect of a patient's condition.
- By combining their expertise, the team develops a treatment strategy that is tailored to the individual's specific type of cancer, stage of disease, diagnostic findings, and overall health.
- The Continuum of Care
Precision Medicine: Treatment Built Around Your Tumour
Precision medicine has transformed modern oncology by recognising that every tumour has its own biological and genetic characteristics. Using information obtained through advanced molecular diagnostics, genetic profiling, and biomarker testing, clinicians can identify therapies that are more likely to be effective for a particular patient. Rather than following a standard treatment pathway, precision medicine enables treatment to be customised according to the unique characteristics of the cancer, helping clinicians make more informed and targeted therapeutic decisions.
- The Continuum of Care
Precision Medicine: Treatment Built Around Your Tumour
Precision medicine has transformed modern oncology by recognising that every tumour has its own biological and genetic characteristics. Using information obtained through advanced molecular diagnostics, genetic profiling, and biomarker testing, clinicians can identify therapies that are more likely to be effective for a particular patient. Rather than following a standard treatment pathway, precision medicine enables treatment to be customised according to the unique characteristics of the cancer, helping clinicians make more informed and targeted therapeutic decisions.
- The Continuum of Care
From Data to Decision: How Your Treatment Plan Comes Together
The integration of multidisciplinary tumour board discussions with precision medicine allows every patient to benefit from coordinated, personalised cancer care. Diagnostic reports, imaging studies, pathology findings, genetic and molecular test results, and previous treatment history are carefully reviewed before recommendations are made. This collaborative process helps determine the most appropriate combination of surgery, chemotherapy, immunotherapy, targeted therapy, radiation therapy, or supportive care based on the patient’s individual clinical needs.
For patients with complex, recurrent, advanced, or rare cancers, a multidisciplinary review provides valuable insights that may not be achieved through an individual consultation alone. It encourages collaboration across specialities, supports timely clinical decision-making, and ensures that treatment recommendations align with the latest evidence and established oncology guidelines. As the patient’s condition evolves, treatment plans can be reassessed and refined to ensure care remains responsive to changing clinical needs.
At Apulki Medical Centre, the Tumour Board & Precision Medicines programme reflects our commitment to delivering personalised, coordinated, and precision-driven cancer care. By combining multidisciplinary expertise with advanced molecular insights, we develop treatment plans tailored to each patient, support informed clinical decisions, and prioritise the best possible outcomes at every stage of the cancer journey.